Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by ninja3925 on Thursday June 22, 2023 @10:06PM
(#36441954)
I somewhat understand your point but the facts imperfectly support it. If information was already priced in, say 90% chance of success, a positive outcome would still provide a lift from the remaining 10%.
The decrease sounds like something else is going on.
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by mhluongo on Thursday June 22, 2023 @10:33PM
(#36442129)
"Buy the rumor, sell the news"
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by throwaway2037 on Friday June 23, 2023 @02:09AM
(#36443412)
2% is nothing for a single name stock. Who cares. It is just noise.
Looking at the close price history here: https://www.google.com/search?q=SRPT+price&rlz=1C1GCEB_enJP1...
Overall, the last one year has been pretty flat for this stock.
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by m3kw9 on Thursday June 22, 2023 @10:45PM
(#36442203)
It’s more like ppl sell because they know bull with this environment will keep buying till news hits
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by fullburley on Friday June 23, 2023 @12:48AM
(#36442905)
The approved label reduced access to 4 and 5 year olds, shrinking the market opportunity in the short term.
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by Cthulhu_ on Friday June 23, 2023 @03:31AM
(#36443888)
Stock prices have nothing to do with the successes or failures of a company, and everything with hype, marketing, and mainstream appeal. Same with cryptocurrencies and the likes. It's not a rational market, but everyone talks about it like it is.
A good example of what it means for news to to be "already priced in," and how in fact, too many traders in a name can overcrowd it and destroy the alpha. It's like game theory.
[1] https://yhoo.it/3pbC6aB